Terms: = Bone cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Treatment
5 results:
1. IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.
Tunalı G; Rúbies Bedós M; Nagarajan D; Fridh P; Papakyriacou I; Mao Y
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36757800
[TBL] [Abstract] [Full Text] [Related]
2. Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
Zeidner JF; Vincent BG; Ivanova A; Moore D; McKinnon KP; Wilkinson AD; Mukhopadhyay R; Mazziotta F; Knaus HA; Foster MC; Coombs CC; Jamieson K; Van Deventer H; Webster JA; Prince GT; DeZern AE; Smith BD; Levis MJ; Montgomery ND; Luznik L; Serody JS; Gojo I
Blood Cancer Discov; 2021 Nov; 2(6):616-629. PubMed ID: 34778801
[TBL] [Abstract] [Full Text] [Related]
3. Long Noncoding RNA hnf1a-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
4. Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.
Zhang HT; Yang J; Liang GH; Gao XJ; Sang Y; Gui T; Liang ZJ; Tam MS; Zha ZG
J Cell Biochem; 2017 Dec; 118(12):4575-4586. PubMed ID: 28485543
[TBL] [Abstract] [Full Text] [Related]
5. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract] [Full Text] [Related]
